Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q2
$227K Buy
+1,764
New +$206K 0.06% 141
2024
Q4
– Sell
-5,340
Closed -$606K – 133
2024
Q3
$606K Sell
5,340
-3,502
-40% -$416K 0.19% 75
2024
Q2
$1.09M Sell
8,842
-2,440
-22% -$314K 0.3% 54
2024
Q1
$1.49M Sell
11,282
-775
-6% -$95.5K 0.42% 49
2023
Q4
$1.31M Sell
12,057
-893
-7% -$92.7K 0.41% 49
2023
Q3
$1.33M Buy
12,950
+2,094
+19% +$226K 0.47% 40
2023
Q2
$1.25M Buy
10,856
+2,471
+29% +$281K 0.46% 43
2023
Q1
$892K Buy
8,385
+6,532
+353% +$705K 0.36% 50
2022
Q4
$206K Buy
+1,853
New +$189K 0.1% 141

Other funds holding MRK

Financial Insights's MRK Position: Q2 2026 in Review

Financial Insights opened a new position in Merck (MRK) in Q2 2026: 1,764 shares worth $227K. The stake represents 0.06% of the portfolio and ranks #141 among its holdings. This is a return to the name: Financial Insights previously reported a position in MRK as recently as Q3 2024.

Financial Insights first reported a position in MRK in Q4 2022 and has held it in 9 quarters since. The position peaked at $1.49M in Q1 2024. 3,852 funds tracked by Wall St. Rank hold MRK as of Q2 2026.

  • Financial Insights held 1,764 shares of Merck worth $227K as of Q2 2026.
  • Merck was a new Financial Insights position in Q2 2026.
  • Merck made up 0.06% of Financial Insights's portfolio in Q2 2026, its #141 holding.
  • Financial Insights first reported a position in Merck in Q4 2022 and has held it in 9 quarters since.
  • Financial Insights's Merck position peaked at $1.49M in Q1 2024.
  • 3,852 funds tracked by Wall St. Rank held Merck as of Q2 2026.

Based on Financial Insights's 13F filing for Q2 2026, filed 25 Aug 2026.